🟢 Indaptus Therapeutics is trading 7.57% up today after a roughly $24 million private placement

Indaptus Therapeutics is trading at $2.98 (+7.57%) as investors continue responding to the company’s September 10 private-placement announcement.

• Financing covers 20,338,974 shares and approximately $24 million in gross proceeds.
• Proceeds are intended for working capital, research, development, and general corporate purposes.
• The stock advanced sharply across recent sessions, including +8.20% on September 11 and +23.08% on September 10.